Related Experiment Videos
Partial laryngectomy for recurrent cancer after irradiation
Clinical Otolaryngology and Allied Sciences
|February 1, 1978
Summary
Partial laryngectomy after radiation offers cure for glottic cancer recurrence. However, horizontal partial laryngectomy for supraglottic cancer recurrence shows concerning complication and survival rates.
Area of Science:
- Otolaryngology
- Oncology
- Surgical Oncology
Background:
- Laryngeal cancer treatment often involves radiation therapy followed by surgery.
- Partial laryngectomy presents unique challenges after full-dose irradiation.
- Assessing outcomes of salvage surgery is crucial for treatment planning.
Purpose of the Study:
- To evaluate the efficacy and complications of partial laryngectomy after radiotherapy for recurrent laryngeal cancer.
- To compare outcomes of vertical versus horizontal partial laryngectomy for glottic and supraglottic recurrences, respectively.
- To define the role of conservation surgery in the context of prior full-dose irradiation.
Main Methods:
- Retrospective analysis of data from two major treatment centers.
- Review of surgical techniques, complication rates, and survival data.
- Focus on partial laryngectomy (vertical and horizontal) as salvage treatment.
Main Results:
- Vertical partial laryngectomy for recurrent glottic cancer demonstrated a reasonable expectation of cure and functional conservation.
- Horizontal partial laryngectomy for recurrent supraglottic cancer was associated with significant complications and poor survival.
- Significant differences in outcomes were observed based on the location of cancer recurrence (glottic vs. supraglottic).
Conclusions:
- Vertical partial laryngectomy is a viable option for selected cases of recurrent glottic cancer post-irradiation.
- Horizontal partial laryngectomy for recurrent supraglottic cancer post-irradiation requires cautious consideration due to high complication and mortality rates.
- Further research is needed to optimize salvage strategies for recurrent laryngeal cancer after radiotherapy.